Factors Associated with Insomnia Symptoms in a Longitudinal Study among New York City Healthcare Workers during the COVID-19 Pandemic

Few studies have examined the longer-term psychological impact of COVID-19 in healthcare workers (HCWs). We examined the 10-week trajectory of insomnia symptoms in HCWs during the COVID-19 pandemic. HCWs completed a web-based survey at baseline (9 April-11 May 2020) and every 2 weeks for 10 weeks. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of environmental research and public health 2021-08, Vol.18 (17), p.8970
Hauptverfasser: Abdalla, Marwah, Chiuzan, Codruta, Shang, Yimeng, Ko, Gavin, Diaz, Franchesca, Shaw, Kaitlin, McMurry, Cara L, Cannone, Diane E, Sullivan, Alexandra M, Lee, Sung A J, Venner, Hadiah K, Shechter, Ari
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Few studies have examined the longer-term psychological impact of COVID-19 in healthcare workers (HCWs). We examined the 10-week trajectory of insomnia symptoms in HCWs during the COVID-19 pandemic. HCWs completed a web-based survey at baseline (9 April-11 May 2020) and every 2 weeks for 10 weeks. The main outcome was the severity of insomnia symptoms in the past week. Multivariable-adjusted generalized estimating equation analyses examined factors associated with insomnia symptoms. = 230 completed surveys at baseline. = 155, = 130, = 118, = 95, and = 89 completed follow-ups at weeks 2, 4, 6, 8, and 10, respectively. Prevalence of insomnia symptoms of at least moderate severity was 72.6% at baseline, and 63.2%, 44.6%, 40.7%, 34.7%, and 39.3% at weeks 2, 4, 6, 8, and 10, respectively. In multivariable analyses, factors significantly associated with increased odds of insomnia symptoms were younger age (OR: 0.98, 95% CI: 0.96-1.00), working in a COVID-facing environment (OR: 1.75, 95% CI: 1.15-2.67) and hours worked (OR: 1.16, 95% CI: 1.06-1.27). The initial high rates of insomnia symptoms improved as time passed from the peak of local COVID-19 cases but four out of ten HCWs still had moderate-to-severe insomnia symptoms ten weeks after baseline.
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph18178970